Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
STALEVO
Generic name / active ingredient
carbidopa, levodopa and entacapone
Dosage-form class
STALEVO fixed three-ingredient film-coated oral tablets: six named strengths, 50, 75, 100, 125, 150 and 200; every tablet contains carbidopa and levodopa plus a fixed 200 mg of entacapone; all are listed as 100-tablet bottles in the U.S. label
Route
Oral (higher-risk fixed three-ingredient product-identity field)
Record reviewed
2026-08-27

Copy from the pack in hand

Source-linked reading points

  • Check STALEVO, all three ingredients, all three milligram amounts per tablet, NDC, 100-tablet bottle, LCE imprint and market together. The '100' in STALEVO 100 names the levodopa component only; the same tablet also contains carbidopa 25 mg and entacapone 200 mg.
  • Do not treat STALEVO as another SINEMET pack. Both may name carbidopa/levodopa, but STALEVO also contains entacapone. Shared ingredients, nearby numbers or a similar purpose do not establish self-co-use, alternation, substitution or stacking. Have a pharmacist or prescriber review both actual packs and the complete medicine list.
  • The current label also addresses hyperpyrexia and confusion after abrupt reduction or withdrawal, falling asleep during daily activities, orthostatic hypotension, dyskinesia, hallucinations, impulse-control problems, diarrhoea and interactions including warfarin. The site only prompts review of symptoms, falls, sleepiness and the complete medicine list; it does not provide self-stopping, reduction, make-up or spacing instructions.
  • For loss of consciousness, a serious fall, breathing difficulty, marked confusion, high fever, suspected overdose or another acute serious concern, use local emergency or poison-information services immediately and bring all medicine packs; do not wait for a web search or try to counteract it with another Parkinson medicine.

Reviewed presentation examples — compare every field

  • STALEVO 50: carbidopa 12.5 mg / levodopa 50 mg / entacapone 200 mg per tablet; 100-tablet bottleNDC 52427-805-01
  • STALEVO 75: carbidopa 18.75 mg / levodopa 75 mg / entacapone 200 mg per tablet; 100-tablet bottleNDC 52427-809-01
  • STALEVO 100: carbidopa 25 mg / levodopa 100 mg / entacapone 200 mg per tablet; 100-tablet bottleNDC 52427-816-01
  • STALEVO 125: carbidopa 31.25 mg / levodopa 125 mg / entacapone 200 mg per tablet; 100-tablet bottleNDC 52427-827-01
  • STALEVO 150: carbidopa 37.5 mg / levodopa 150 mg / entacapone 200 mg per tablet; 100-tablet bottleNDC 52427-834-01
  • STALEVO 200: carbidopa 50 mg / levodopa 200 mg / entacapone 200 mg per tablet; 100-tablet bottleNDC 52427-842-01

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-27
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image